Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Soho Global Health TbkISX:SOHO +0.42%87 Gross Margin % is 19.78% as of Jun. 2026, which is 8% above its 10-year median of 18.36. GuruFocus rates ISX:SOHO with a GF Score™ of 87/100 and a GF Value™ of Rp805.04 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 120 Medical Distribution companies, PT Soho Global Health Tbk ranks better than 56.67% on this metric.
ISX:SOHO's Gross Margin % is ranked better than 56.67% of 120
companies
in the Medical Distribution industry
Industry Median: 15.015
vs ISX:SOHO: 18.37
PT Soho Global Health Tbk had a gross margin of 19.78% for the quarter that ended in Jun. 2026 => No sustainable competitive advantage
PT Soho Global Health Tbk (ISX:SOHO) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
PT Soho Global Health Tbk had a gross margin of 19.78% for the quarter that ended in Jun. 2026 => No sustainable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
PT Soho Global Health Tbk Gross Margin % Related Terms
PT Soho Global Health Tbk Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ISX:SOHO vs MCK, COR, CAH: Gross Margin % Comparison
For the Medical Distribution subindustry, PT Soho Global Health Tbk's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Soho Global Health Tbk Gross Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, PT Soho Global Health Tbk's Gross Margin % distribution charts can be found below:
* The bar in red indicates where PT Soho Global Health Tbk's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
PT Soho Global Health Tbk (ISX:SOHO) has a Gross Margin % of 19.78% as of Jun. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on PT Soho Global Health Tbk and its competitors. This is near median its historical median of 18.36. Over the past decade, PT Soho Global Health Tbk's Gross Margin % has ranged from 15.32 to 22.18. According to the industry distribution chart, PT Soho Global Health Tbk ranks #52 out of 120 companies in the Medical Distribution industry, placing it in the top 43.3%.
Is PT Soho Global Health Tbk's Gross Margin % too high?
PT Soho Global Health Tbk's current Gross Margin % of 19.78% is near median its 10-year median of 18.36. Over the past 10 years, this metric has ranged from a low of 15.32 to a high of 22.18. The Medical Distribution industry median Gross Margin % is 15.02. PT Soho Global Health Tbk's value of 19.78% is 31.7% above this industry median. Based on the distribution chart, PT Soho Global Health Tbk ranks #52 out of 120 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, PT Soho Global Health Tbk has a GF Score™ of 87/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PT Soho Global Health Tbk's Gross Margin % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, PT Soho Global Health Tbk ranks #52 out of 120 companies for Gross Margin %. This puts PT Soho Global Health Tbk in the upper half of its industry. The industry median Gross Margin % is 15.02. PT Soho Global Health Tbk's value of 19.78% is 31.7% above this benchmark. Historically, PT Soho Global Health Tbk's own Gross Margin % has ranged from 15.32 to 22.18 over the past decade. While the company's 10-year median is 18.36 vs. the industry median of 15.02, PT Soho Global Health Tbk has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Distribution company?
The median Gross Margin % among Medical Distribution companies is 15.02, based on 120 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Soho Global Health Tbk's current Gross Margin % of 19.78% is 31.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on PT Soho Global Health Tbk and its competitors. For the Medical Distribution industry, the median Gross Margin % is 15.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Soho Global Health Tbk's current Gross Margin % is 19.78%, which is near median its own 10-year median of 18.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Soho Global Health Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Soho Global Health Tbk (ISX:SOHO) is currently considered Significantly Overvalued. The stock's GF Value™ is Rp805.04, compared to a current price of Rp1,205.00 — trading 49.7% above its estimated fair value. The current Gross Margin % is 19.78%, which is near median its 10-year median of 18.36 and 31.7% above the Medical Distribution industry median of 15.02. PT Soho Global Health Tbk's overall GF Score™ is 87/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For PT Soho Global Health Tbk (ISX:SOHO), the current Gross Margin % is 19.78% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Soho Global Health Tbk (ISX:SOHO) Overvalued in 2026?
Based on GuruFocus' analysis, PT Soho Global Health Tbk stock appears to be overvalued.
The current stock price of Rp1,205.00 is trading 49.7% above its estimated GF Value™ of Rp805.04.
GuruFocus considers PT Soho Global Health Tbk to be Significantly Overvalued.
Key valuation signals for ISX:SOHO:
Gross Margin %: 19.78% (near median its 10-year median of 18.36)
GF Value™: Rp805.04 vs. price of Rp1,205.00 (49.7% above fair value)
Industry Position: 31.7% above the Medical Distribution median (#52 of 120)
No single metric tells the full story. See the ISX:SOHO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Soho Global Health Tbk is a healthcare company operating in the areas of natural/herbal health care products and services. The company manufactures and distributes pharmaceutical products, including herbal cures, proprietary medicines, and health foods, under various brand names such as Curcuma Plus, Curcuma Plus Milk; Imboost; Fitkom; Diapet; Laxing; Lelap; Asthma Soho, and Sohobion. Its segment includes Distribution, Consumer health, Alliance, and others. The company generates maximum revenue from the Distribution segment.
87GF Score
Get the complete analysis for ISX:SOHO
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:SOHO has been successfully added to your 
